Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)

NCT00452244 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

OTHER_GOV

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: simvastatin
DRUG: gefitinib only

Sponsor

National Cancer Center, Korea